Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 46, Issue 5

Issues

Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications

Belén Prieto / Elena Llorente / Ignacio González-Pinto / Francisco V. Alvarez
  • 4Hospital Universitario Central de Asturias, Servicio de Bioquímica, Oviedo, Spain and Departamento de Bioquímica y Biología Molecular, Universidad de Oviedo, Oviedo, Spain
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2008-03-14 | DOI: https://doi.org/10.1515/CCLM.2008.123

Abstract

Background: Elevated procalcitonin (PCT) levels are observed after major surgery, such as orthotopic liver transplantation (OLTx). The aim of this observational study was to evaluate PCT kinetics during the first 5 following days after surgery to establish the prognostic value of PCT changes in the outcome of OLTx, and to predict medical, technical and infectious complications. PCT was also evaluated in the differential diagnosis of infection vs. rejection.

Methods: A total of 64 OLTx were performed in 58 patients; they were split into two groups: with and without complications. Out of these patients, 18 developed infection, and nine rejection. PCT was measured before and during surgery, 12 h after transplantation and daily for the 5 following days. PCT was also measured the day when infection or rejection was diagnosed, and on the previous day. PCT was determined by time-resolved amplified cryptate emission (TRACE) technology.

Results: PCT elevation began at 12 h after surgery, reaching a peak on the 1st day in both groups. Significantly higher PCT concentrations were found in the group of patients developing complications, on the 5 postoperative days. It was found that a 24 h PCT value higher than 1.92 μg/L increased by 9.1-time-fold the risk of complications. When infection was diagnosed, a second peak of PCT was observed, but no PCT elevation was shown in rejection.

Conclusions: Daily monitored PCT provides valuable information about the early outcome of OLTx.

Clin Chem Lab Med 2008;46:660–6.

Keywords: immediate complications; infection; liver transplantation; procalcitonin; rejection

About the article

Corresponding author: Belén Prieto García, PhD, Hospital Universitario Central de Asturias, c/Celestino Villamil, s/n – 33006 Oviedo, Spain Phone/Fax: +34-985-108073,


Received: 2007-10-03

Accepted: 2008-01-18

Published Online: 2008-03-14

Published in Print: 2008-05-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 46, Issue 5, Pages 660–666, ISSN (Online) 14374331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2008.123.

Export Citation

©2008 by Walter de Gruyter Berlin New York.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
T. D. Smirnova, S. N. Shtykov, and E. A. Zhelobitskaya
Physical Sciences Reviews, 2018, Volume 0, Number 0
[2]
KATSUHIRO MASAGO, AKIKO FUKUHARA, YUTAKA ITO, YUKIMASA HATACHI, KAORU IRISA, YUICHI SAKAMORI, YOSUKE TOGASHI, SHIRO FUJITA, YOUNG HAK KIM, TADASHI MIO, and MICHIAKI MISHIMA
Oncology Letters, 2010, Volume 1, Number 5, Page 849
[3]
Experimental and Clinical Transplantation, 2016, Volume 14, Number Suppl 3
[4]
Uriel Sandkovsky, Andre C. Kalil, and Diana F. Florescu
Clinical Transplantation, 2015, Volume 29, Number 8, Page 689
[5]
X.-Y. Yu, Y. Wang, H. Zhong, Q.-L. Dou, Y.-L. Song, and H. Wen
Transplantation Proceedings, 2014, Volume 46, Number 1, Page 26
[6]
Tassos Grammatikopoulos, Anil Dhawan, Sanjay Bansal, Jim Wade, Roy Sherwood, Tracy Dew, Nigel Heaton, and Anita Verma
Clinics and Research in Hepatology and Gastroenterology, 2012, Volume 36, Number 4, Page 365
[7]
Belén Prieto García, Tamara de la Cera Martínez, Elena Llorente Fernández, and Francisco V. Álvarez Menéndez
Revista del Laboratorio Clínico, 2009, Volume 2, Number 2, Page 99
[8]
A. Perrakis, S. Yedibela, V. Schellerer, W. Hohenberger, and V. Müller
Transplantation Proceedings, 2010, Volume 42, Number 10, Page 4187
[10]
I. González-Busto Múgica, J. Prieto Rodríguez, A. Fernández Fernández, R. Hueso Rieu, F.V. Álvarez Menéndez, and A. Amigo Fernández
Revista Española de Cirugía Ortopédica y Traumatología (English Edition), 2011, Volume 55, Number 2, Page 130
[11]
I. González-Busto Múgica, J. Prieto Rodríguez, A. Fernández, R. Hueso Rieu, F.V. Álvarez Menéndez, and A. Amigo Fernández
Revista Española de Cirugía Ortopédica y Traumatología, 2011, Volume 55, Number 2, Page 130
[12]
Maartje A. J. van den Broek, Steven W. M. Olde Damink, Bjorn Winkens, Christoph E. Broelsch, Massimo Malagó, Andreas Paul, and Fuat H. Saner
Liver Transplantation, 2010, Volume 16, Number 3, Page 402
[13]
Christian P. Schneider, Yeshim Yilmaz, Axel Kleespies, Karl-Walter Jauch, and Wolfgang H. Hartl
Shock, 2009, Volume 31, Number 6, Page 569

Comments (0)

Please log in or register to comment.
Log in